TScan Therapeutics, Inc. TCRX Q1 2025 earnings
Reported May 6, 2025 · Before market open
Revenue$2.2MBeat by $1.1M
EPS-$0.26Beat by $0.02
Revenue estimate$1.1M
EPS estimate-$0.28
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$1.9M
EPS estimate-$0.29
Versus estimates
Revenue
Diluted EPS
Ask the moment TScan Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did TScan Therapeutics, Inc. report Q1 2025 earnings?
- TScan Therapeutics, Inc. (TCRX) reported Q1 2025 earnings on May 6, 2025 before market open.
- What were TScan Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- TScan Therapeutics, Inc. reported revenue of $2.2M and eps of $-0.26 for Q1 2025.
- Did TScan Therapeutics, Inc. beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $1.1M by $1.1M. EPS beat the consensus estimate of $-0.28 by $0.02.
- How did TScan Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 283.6% from $566.0K a year earlier and eps grew 18.8% from $-0.32.
- Where can I find TScan Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-063968) directly on SEC EDGAR. The filing index links above go to sec.gov.